Tag Archives: $8.00
Avanir Pharmaceuticals, AVNR Upgrade to a buy
AVNR upgraded to a buy with a price target of $8.00, Cantor Fitzgerald Initiates Coverage on Avanir Pharmaceuticals with a buy, Avanir Pharmaceuticals, Inc. ANVR is a pharmaceutical company focused on acquiring, developing and commercializing therapeutic products for the treatment of central nervous system disorders. Shares trading up 23 cents, Shares closed @ $2.22 yesterday.
